The Age
·general
·1 hour ago
Perth biotech Syngenis unleashes AI drug discovery push
Perth biotech Syngenis Laboratories launched Syngenis Discovery, an AI-powered platform designed to accelerate drug discovery by compressing traditional workflows from months to hours. The platform analyzes billions of molecular combinations using machine learning to identify viable treatments, particularly for RNA and DNA-based oligonucleotide therapeutics. Syngenis plans an ASX listing this year to expand operations.
Summary by Glance · The Age
Newer
Next
Loving doing this? 🎉
Take it further — get the full app and never miss a moment of what's happening in Australia.
Breaking news alerts
Instant lock-screen notifications the moment big stories break across Australia.
Australian news & events
Politics, sport, weather, local events — all in one swipeable feed, updated around the clock.
Stay ahead of the news cycle
30-second summaries so you're always informed, even on your busiest days.
Loading article…
This publisher's site can't be shown here due to their security settings.
Open full article →No source link available for this article.
✨
Ask AI